Upexi, Inc.
Upexi, Inc. (UPXI) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Upexi, Inc. (UPXI), covering cash flow, earnings, and balance sheets.
Upexi, Inc. (UPXI) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Upexi, Inc. UPXI financial performance.
Metric | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
---|---|---|---|---|
Revenue | $3.16M | $4.005M | $4.36M | -$33.59M |
Cost of Revenue | $1.60M | $1.03M | $1.43M | -$29.69M |
Gross Profit | $1.56M | $2.97M | $2.93M | -$7.04M |
Gross Profit Ratio | $0.49 | $0.74 | $0.67 | $0.21 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $3.68M | $3.81M | $4.006M | $1.95M |
Operating Expenses | $3.68M | $4.05M | $4.27M | $10.60M |
Total Costs & Expenses | $5.28M | $5.08M | $5.69M | -$19.09M |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | -$245103.00 | $0.00 | $290412.00 | $0.00 |
Depreciation & Amortization | $0.00 | $239752.00 | $259095.00 | $919697.00 |
EBITDA | -$3.59M | -$833447.00 | -$1.08M | -$24.36M |
EBITDA Ratio | -$1.14 | -$0.21 | -$0.25 | $0.73 |
Operating Income | -$3.59M | -$1.07M | -$1.34M | -$14.60M |
Operating Income Ratio | -$1.14 | -$0.27 | -$0.31 | $0.43 |
Other Income/Expenses (Net) | -$244427.00 | -$228111.00 | -$290412.00 | -$476251.00 |
Income Before Tax | -$3.83M | -$1.30M | -$1.63M | -$14.86M |
Income Before Tax Ratio | -$1.21 | -$0.32 | -$0.37 | $0.44 |
Income Tax Expense | $0.00 | $0.00 | $0.00 | $2.34M |
Net Income | -$3.83M | -$1.30M | -$1.63M | -$15.75M |
Net Income Ratio | -$1.21 | -$0.32 | -$0.37 | $0.47 |
EPS | -$2.87 | -$1.24 | -$1.55 | -$15.33 |
Diluted EPS | -$2.87 | -$1.24 | -$1.55 | -$15.33 |
Weighted Avg Shares Outstanding | $1.34M | $1.05M | $1.05M | $1.03M |
Weighted Avg Shares Outstanding (Diluted) | $1.34M | $1.05M | $1.05M | $1.05M |
Over the last four quarters, Upexi, Inc. achieved steady financial progress, growing revenue from -$33.59M in Q4 2024 to $3.16M in Q3 2025. Gross profit stayed firm with margins at 49% in Q3 2025 versus 21% in Q4 2024. Operating income totaled -$3.59M in Q3 2025, maintaining a -114% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at -$3.59M. Net income dropped to -$3.83M, with EPS at -$2.87. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan